
Amarin Corporation plc
AMRNNASDAQ
USReal-Time Price
$11.75USD
+0.22 (+1.91%)Today
BTI Score
Near Future
46
Long Term
51
BTI Fair Market Cap
$523.57M
-53.58% vs fair
Healthcare & Pharma
Hold
Amarin Corporation plc (AMRN) Stock Analysis
BTI's proprietary analysis of Amarin Corporation plc (AMRN): overall score, long- and short-term outlook, risk rating and fair-value verdict based on fundamentals, valuation and momentum.
Major-Firm Consensus
Sell
Filtered to 7 major global investment banks
Buy
0
Hold
2
Sell
5
Price Target Consensus
High
$13.00
Consensus
$12.50
Low
$12.00
Current
$11.75
Upside: +6.4%
Target Trend
Last Month— (0)
Last Quarter— (0)
Last Year— (0)
Annual Analyst Estimates
| Fiscal Year | Revenue Avg | Revenue Range | EPS Avg | EPS Range | Analysts |
|---|---|---|---|---|---|
| FY 2026 | $177.4M | — – — | — | — – — | — |
| FY 2027 | $176.8M | — – — | — | — – — | — |
Want deeper AI-powered analysis?
Get BTI AI's full investment thesis, valuation models, and risk assessment for AMRN.


